Literature DB >> 25307548

Biomarkers in pediatric heart disease.

Hythem Nawaytou1, Harold S Bernstein.   

Abstract

A biomarker is a characteristic that can be used as an indicator of a biological state. A biomarker can be a clinical observation, laboratory test or an imaging parameter. In this review, we discuss the use of biomarkers in differentiating cardiac from noncardiac disease; predicting the prognosis of patients with heart failure, pulmonary hypertension and dilated cardiomyopathy; diagnosing subclinical cardiac involvement in muscular dystrophy and postchemotherapy cancer patients; detecting acute rejection following heart transplantation; diagnosing Kawasaki disease; aiding the management of postoperative cardiac patients; and managing both common (tetralogy of Fallot) and complex (single-ventricle physiology) congenital heart diseases.

Entities:  

Keywords:  Kawasaki disease; biomarker; cardiomyopathy; cardiotoxicity; congenital heart disease; heart failure; heart transplant; natriuretic peptides; postoperative; pulmonary hypertension

Mesh:

Substances:

Year:  2014        PMID: 25307548     DOI: 10.2217/bmm.14.37

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  2 in total

1.  Postoperative Serum Troponin Trends in Infants Undergoing Cardiac Surgery.

Authors:  Jennifer A Su; S Ram Kumar; Hesham Mahmoud; Michael E Bowdish; Omar Toubat; John C Wood; Grace C Kung
Journal:  Semin Thorac Cardiovasc Surg       Date:  2018-09-06

2.  Assessment of N-terminal prohormone B-type natriuretic peptide as a measure of vascular and ventricular function in pediatric pulmonary arterial hypertension.

Authors:  Vitaly O Kheyfets; Jamie Dunning; Uyen Truong; D Dunbar Ivy; Kendall A Hunter; Robin Shandas
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.